1 / 4

Connected Drug Delivery Devices Market

Connected Drug Delivery Devices Market

Nandini11
Download Presentation

Connected Drug Delivery Devices Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Connected Drug Delivery Devices Market: Global Size, Trends, Competitive, And Historical & Forecast Analysis, 2022-2028: The need to boost patient medication adherence, acceleration of remote digital monitoring, and R&D activities are some of the major factors driving the growth of the Global Connected Drug Delivery Devices Market. Global Connected Drug Delivery Devices Marketis valued at USD 4.63 Billion in 2021 and expected to reach USD 7.99 Billion by 2028 with a CAGR of 50.21% over the forecast period. Scope- In residential settings, connected medication delivery devices are smart wireless electronic solutions that facilitate the monitoring of patients and counselling. They are equipped with adherence trackers, sensors, monitoring systems, dosage reminders, and teaching tools that provide real-time feedback and tailored patient care. Key Players- Some major key players for the global Connected Drug Delivery Devices market report cover prominent players like - •Novo Nordisk A/S •Teva Respiratory LLC •Medtronic •Phillips-Medisize LLC •Tandem Diabetes Care Inc. •Adherium Limited •Propeller health •Biocorp •Ypsomed AG •Aptar Pharma •others Segmentation- By Device Type: •Connected Sensors •Integrated Devices

  2. By Technology: •Bluetooth •Near Field Communication •Service By Application: •Respiratory •Cardiovascular •Anaphylaxis •Hormone Replacement •Diabetes •Others By End-Use: •Hospital •Clinics •Homecare •Others By Regional & Country Level: • North America oU.S. oCanada • Europe oU.K. oFrance oGermany oItaly • Asia Pacific oChina oJapan oIndia oSoutheast Asia • Latin America oBrazil oMexico • Middle East and Africa oGCC

  3. oAfrica oRest of Middle East and Africa The need to boost patient medication adherence, acceleration of remote digital monitoring, and R&D activities are some of the major factors driving the growth of the Global Connected Drug Delivery Devices Market Growth One of the main factors driving the market is the rise in R&D activity. Due to the strong product offerings of numerous important participants, which is predicted to be commercially released throughout the projection period, it also adds to an exponentially growing rate. North America is Expected to Capture a Major Share in the Global Connected Drug Delivery Devices Market Due to the increased prevalence of chronic illnesses and the existence of a sizable target population, North America is predicted to be the region with the greatest market for linked medication delivery systems News- Aptar Pharma Launches HeroTracker Sense On February 8th, 2022; Aptar Pharma announced the launch of HeroTracker Sense, a breakthrough digital respiratory healthcare system that transforms a typical metered dosage inhaler into a smart linked healthcare system. Aptar Pharma is a global leader in medication delivery devices, services, and active material science solutions. Jabil Healthcare Announces the Launch of the Qfinity On May 18th, 2022; A platform named QfinityTM autoinjector was introduced by Jabil Healthcare, a significant international provider of healthcare manufacturing solutions. When compared to other options on the market, this platform offers a reusable and integrated solution for subcutaneous (SC) medication self-administration at a reasonable cost. Nemera inaugurated a new facility in Lyon On September 19th, 2022; Nemera has opened a new facility in Lyon, France, which will serve as the company's current European headquarters and innovation hub.

More Related